| 1 |
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
Japanese Society for Cancer of the Colon and Rectum et al. · International Journal of Clinical Oncology
Open access |
27 Mar 2017 |
2,496 |
| 2 |
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Yojiro Hashiguchi et al. · International Journal of Clinical Oncology
Open access |
15 Jun 2019 |
2,012 |
| 3 |
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2 -Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study
Taroh Satoh, Rui‐Hua Xu, Hyun Cheol Chung et al. · Journal of Clinical Oncology
Open access |
28 May 2014 |
630 |
| 4 |
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
Yasuhide Yamada et al. · Annals of Oncology
Open access |
15 Oct 2014 |
546 |
| 5 |
Diagnosis and management of insulinoma
Takehiro Okabayashi · World Journal of Gastroenterology
Open access |
2013 |
475 |
| 6 |
TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Takayuki Yoshino, Nobuyuki Mizunuma, Kentaro Yamazaki et al. · The Lancet Oncology
|
27 Aug 2012 |
326 |
| 7 |
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
Shigeatsu Endo, Yasushi A Suzuki, Gaku Takahashi et al. · Journal of Infection and Chemotherapy
|
2012 |
326 |
| 8 |
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
K. Yamazaki et al. · Annals of Oncology
Open access |
14 May 2016 |
285 |
| 9 |
Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease
Yasuharu Sato, Masaru Kojima, Katsuyoshi Takata et al. · Modern Pathology
Open access |
6 Mar 2009 |
283 |
| 10 |
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial
Yukihide Kanemitsu et al. · Journal of Clinical Oncology
|
14 Sep 2021 |
228 |
| 11 |
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
Yukihide Kanemitsu et al. · Journal of Clinical Oncology
Open access |
9 Feb 2021 |
204 |
| 12 |
A nationwide survey on the incidence and characteristics of traumatic spinal cord injury in Japan in 2018
Naohisa Miyakoshi, Kota Suda, Daisuke Kudo et al. · Spinal Cord
|
11 Aug 2020 |
166 |
| 13 |
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
Takayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada et al. · Investigational New Drugs
Open access |
11 Sep 2014 |
123 |
| 14 |
Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma
Ken Kato, Yoshinori Ito, Isao Nozaki et al. · Gastroenterology
Open access |
10 Aug 2021 |
121 |
| 15 |
Circulating pancreatic cancer exosomal RNA s for detection of pancreatic cancer
Tatsuya Kitagawa, Keisuke Taniuchi, Makiko Tsuboi et al. · Molecular Oncology
Open access |
25 Oct 2018 |
120 |
| 16 |
Intensive Versus Intermediate Glucose Control in Surgical Intensive Care Unit Patients
Takehiro Okabayashi, Yasuo Shima, Tatsuaki Sumiyoshi et al. · Diabetes Care
Open access |
12 Mar 2014 |
120 |
| 17 |
Mammary Analogue Secretory Carcinoma of Salivary Glands
Yôhei Itô, Kenichiro Ishibashi, Ayako Masaki et al. · The American Journal of Surgical Pathology
|
4 Feb 2015 |
116 |
| 18 |
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study
Toshikazu Moriwaki et al. · The Oncologist
Open access |
11 Sep 2017 |
107 |
| 19 |
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System
Chigusa Morizane et al. · JAMA Oncology
Open access |
19 Aug 2022 |
103 |
| 20 |
Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: A multicenter prospective study
Shigeatsu Endo, Yasushi A Suzuki, Gaku Takahashi et al. · Journal of Infection and Chemotherapy
|
11 Dec 2013 |
96 |
| 21 |
Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
Tatsuaki Sumiyoshi, Yasuo Shima, Takehiro Okabayashi et al. · World Journal of Surgery
|
6 Mar 2018 |
94 |
| 22 |
Effect of Early vs Delayed Surgical Treatment on Motor Recovery in Incomplete Cervical Spinal Cord Injury With Preexisting Cervical Stenosis
The OSCIS investigators et al. · JAMA Network Open
Open access |
9 Nov 2021 |
84 |
| 23 |
Phase II trial of nanoparticle albumin‐bound paclitaxel as second‐line chemotherapy for unresectable or recurrent gastric cancer
Yasutsuna Sasaki, Tomohiro Nishina, Hirofumi Yasui et al. · Cancer Science
Open access |
10 Apr 2014 |
83 |
| 24 |
A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial
Chu Matsuda, Megumi Ishiguro, Satoshi Teramukai et al. · European Journal of Cancer
Open access |
17 Apr 2018 |
82 |
| 25 |
Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912
Daisuke Takahari, Narikazu Boku, Junki Mizusawa et al. · The Oncologist
Open access |
25 Mar 2014 |
81 |
| 26 |
A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy
Takako Yanai, Satoru Iwasa, Hironobu Hashimoto et al. · International Journal of Clinical Oncology
|
16 Oct 2017 |
76 |
| 27 |
Phase I/ II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer ( JCOG 0807)
Shuichi Hironaka, Yasuhiro Tsubosa, Junki Mizusawa et al. · Cancer Science
Open access |
18 Jul 2014 |
72 |
| 28 |
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
Takayuki Yoshino et al. · Annals of Oncology
Open access |
2020 |
69 |
| 29 |
Remote Management of Pacemaker Patients With Biennial In-Clinic Evaluation
Eiichi Watanabe, Fumio Yamazaki, Toshihiko Goto et al. · Circulation Arrhythmia and Electrophysiology
Open access |
28 Apr 2020 |
68 |
| 30 |
Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study
Akihito Kawazoe et al. · European Journal of Cancer
Open access |
9 Mar 2020 |
63 |
| 31 |
Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial
Tetsuya Hamaguchi et al. · The Lancet. Gastroenterology & hepatology
|
24 Oct 2017 |
63 |
| 32 |
Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma
Koji Uotani, Tomohiro Fujiwara, Aki Yoshida et al. · Scientific Reports
Open access |
Nov 2017 |
63 |
| 33 |
Impact of Perioperative Immunonutrition on Postoperative Outcomes for Patients Undergoing Head and Neck or Gastrointestinal Cancer Surgeries
Ryota Matsui, Masano Sagawa, Akihiko Sano et al. · Annals of Surgery
Open access |
26 Oct 2023 |
60 |
| 34 |
Surgical Outcomes of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus
Dong‐Sik Kim et al. · Annals of Surgery
Open access |
26 Sep 2018 |
59 |
| 35 |
Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial
Toshihiko Doi, Satoru Iwasa, Kei Muro et al. · Gastric Cancer
Open access |
4 Dec 2018 |
58 |
| 36 |
Permanent End-Sigmoid Colostomy Through the Extraperitoneal Route Prevents Parastomal Hernia After Laparoscopic Abdominoperineal Resection
Madoka Hamada, Kazuhide Ozaki, Genya Muraoka et al. · Diseases of the Colon & Rectum
|
8 Aug 2012 |
58 |
| 37 |
Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy
Kenta Sui, Takehiro Okabayshi, Jun Iwata et al. · Surgery Today
|
28 Dec 2017 |
56 |
| 38 |
Introducing the eighth edition of the tumor-node-metastasis classification as relevant to colorectal cancer, anal cancer and appendiceal cancer: a comparison study with the seventh edition of the tumor-node-metastasis and the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma
Dai Shida, Yukihide Kanemitsu, Tetsuya Hamaguchi et al. · Japanese Journal of Clinical Oncology
|
27 Dec 2018 |
54 |
| 39 |
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer
Hideaki Bando et al. · Gastric Cancer
Open access |
16 Oct 2015 |
53 |
| 40 |
Clinicopathological features and surgical outcomes of intraductal tubulopapillary neoplasm of the pancreas: a systematic review
Keiichi Date, Takehiro Okabayashi, Yasuo Shima et al. · Langenbeck s Archives of Surgery
Review |
21 Mar 2016 |
51 |
| 41 |
Impact of chorioamnionitis on short- and long-term outcomes in very low birth weight preterm infants: the Neonatal Research Network Japan
Kentaro Miyazaki, Madoka Furuhashi, Kaoru Ishikawa et al. · The Journal of Maternal-Fetal & Neonatal Medicine
|
8 Jan 2015 |
51 |
| 42 |
Incidence and Risk Factors of Cholangitis after Hepaticojejunostomy
Takehiro Okabayashi, Yasuo Shima, Tatsuaki Sumiyoshi et al. · Journal of Gastrointestinal Surgery
|
22 Dec 2017 |
50 |
| 43 |
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients
Won Young Tak et al. · Investigational New Drugs
|
10 Sep 2018 |
49 |
| 44 |
Optical Coherence Tomography Findings in Lesions After Sirolimus-Eluting Stent Implantation With Peri-Stent Contrast Staining
Takeshi Tada et al. · Circulation Cardiovascular Interventions
Open access |
26 Sep 2012 |
49 |
| 45 |
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08
Toshiki Masuishi et al. · British Journal of Cancer
Open access |
31 Aug 2020 |
48 |
| 46 |
Diagnostic accuracy of procalcitonin and presepsin for infectious disease in patients with acute kidney injury
Gaku Takahashi, Shigehiro Shibata, Yasuo Fukui et al. · Diagnostic Microbiology and Infectious Disease
|
18 Jul 2016 |
48 |
| 47 |
Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation
Takeshi Tada et al. · European Heart Journal - Cardiovascular Imaging
|
9 Mar 2015 |
48 |
| 48 |
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)
Hideyuki Ishida et al. · Journal of the Anus Rectum and Colon
Open access |
2018 |
47 |
| 49 |
Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: Inverse probability of treatment weighting with survival analysis
Yuzo Umeda, Toshiharu Mitsuhashi, Toru Kojima et al. · Journal of Hepato-Biliary-Pancreatic Sciences
Open access |
2 Sep 2021 |
46 |
| 50 |
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials
Yu Sunakawa, Wataru Ichikawa, Akihito Tsuji et al. · Clinical Colorectal Cancer
|
10 Oct 2016 |
46 |